Overdose awareness and coronavirus (COVID-19). by unknown
 Overdose Awareness and Coronavirus (COVID-19) 
Information for staff 
There are increased risks for people who use drugs during this time. 
People who use drugs are at increased risk of illness from COVID-19. As well as this, they are at 
increased risk of overdose if they have contracted the illness, as this can cause breathing difficulties 
which may be exacerbated by using a drug such as heroin which can cause respiratory depression. As 
this is a new virus, we continue to learn about the impact it can have on people who use drugs. 
It is known that there are a number of reasons why people who use drugs are at greater risk: 
- Ireland’s ageing cohort of opioid users are particularly vulnerable because of their high level 
of pre-existing health problems and lifestyle factors 
- Risks are increased by the high level of physical and psychological comorbidity found among 
some people who use drugs 
- Drug use can weaken the  immune system making people at greater risk of  illness from 
COVID-19 
- The main life-threatening effects of any opioid, such as heroin, are to slow down and stop a 
person from breathing. Because COVID-19 (like any severe infection of the lung) can cause 
breathing difficulties, there may be an increase in the risk of overdose for people who use 
opioids 
- The prevalence of chronic obstructive pulmonary diseases (COPD) and asthma are high 
among clients in drug treatment, and smoking of heroin or crack cocaine can be an 
aggravating factor  
- The prevalence of HIV, viral hepatitis infections and liver cancers – leading to weakened 
immune systems – is high among people who inject drugs. 
- Tobacco smoking and nicotine dependence are very common among people who use drugs 
and may increase their risks of experiencing more negative outcomes. 
Discussion points with clients in relation to OST 
- The effects of methadone last much longer than the effects of heroin. A single dose of 
methadone lasts for about 24 hours, whereas a single dose of heroin may only have an 
effect for between 4 and 6 hours.  
- People are most at risk of overdose within the first four weeks starting OST, so it is 
important to try and reduce the harms as much as possible for people during this time 
People are at risk of overdose or death if they use heroin, alcohol or other drugs with their 
OST 
- Naloxone should be offered to all people who use drugs and those on OST 
- The National Drug Treatment Centre leaflet on methadone should be given to all clients on 
OST 
Advice to help people reduce the harms if on OST in isolation: 
- Talk to your prescriber if you use street tablets or other drugs  
- Talk to your prescriber about cravings and how you are feeling once on OST. 
- Stick to the OST prescribing plans 
- Missing doses could lead to withdrawal 
- Write down your prescribing plans and remind yourself when you have taken your dose. 
- Store your OST somewhere safe, away from children or others. 
- Avoid using other drugs while on OST: Using drugs with prescription opioids can cause 
overdose or death. This includes using with prescription drugs like benzos/Xanax and 
alcohol. 
- Let a friend or staff member know if you think you are an overdose risk so they can check 
in on you: It is dangerous if you overdose in isolation on your own.  
- You can never be fully sure of the contents of drugs: we are not yet sure what impact this 
situation will have on the drug markets and the contents of drugs. 
- Don’t be afraid to get medical help if you feel unwell after using drugs: there is no 
judgment if you need to get help; we want to help keep you safe.  
The risk of overdose increases if; 
- You  use OST outside of recommendations 
- You use drugs, alcohol or prescription medication with OST 
- You don’t take your OST and start using heroin again 
- You are using in a new environment  
- You are alone and there is no one there to help 
- You are sick or rundown, such as being unwell from Coronavirus 
- If you use new types of drugs,  you may be taking stronger drugs and/or unknown 
substances  
Signs of overdose 
 Change in breathing/ slowed down breathing/choking, coughing, gurgling or snoring sounds 
 Tightness in chest 
 Can’t be woken up or coma 
 Blue/grey lips or finger tips 
 Floppy arms and legs 
CPR 
Please note that if CPR is required during the response to an overdose, breaths or pocket mask 
should not be used - only chest compressions. If the service or staff have access to the use of a Bag 
Valve Mask (BVM) with the appropriate viral filter and have been trained in the use of this 
equipment then this can be used. Please see advice in this regard issued by PHECC (appendix 1). If 
phoning for Emergency services please remember to provide the EirCode if available. 
Appendix 1: PHECC COVID‐19 Advisory v1 
20th March 2020 
 
To: All PHECC Responders, Registered Practitioners, Recognised Institutions, Approved Training 




The global pandemic of SARS NCOV2 (COVID‐19) has resulted in significant challenges and changes in 
how healthcare (including pre‐hospital care) is being delivered in Ireland. 
 
This innovation and flexibility is likely to be required even more in the weeks ahead. 
 
The PHECC Medical Advisory Committee wishes to provide guidance to practitioners and responders 
of all levels at this time. We are conscious that many individual licensed CPG providers and others 
are already taking steps to deliver their services in this context and also to support the state in how 
we all manage this unprecedented situation. 
 
The overarching national guidelines on precautions and clinical management of COVID‐19 are issued 
by the Health Protection Surveillance Centre (HPSC) and updated regularly with input from a 
national Expert Advisory Group (EAG). This should be your main source of accurate information 
along with the HSE and Department of Health; there is a lot of information in circulation regarding 
COVID-19, not all of it accurate. There are some specific issues that are pertinent to pre-hospital 
care, which PHECC would like to highlight in patients with confirmed or suspected COVID‐19 
infection. This advisory guidance is intended to complement existing HPSC guidelines and your own 
training. 
The Medical Directors for licensed CPG providers may issue updated advice based on evolving 
national guidance ‐ please be cognisant of any such advice. 
 
COVID‐19 
The SARS NCOV2 virus which causes COVID‐19, infects through contact with the mucous 
membranes. It does not infect through the skin. 
 
The greatest element of risk for a healthcare worker (responders and practitioners) is transfer of the 
virus to the mucous membranes by contact of contaminated hands (including contaminated gloved 
hands) with the eyes, nose or mouth. The key interventions to manage this risk are to minimise hand 
contamination (keep your hands to yourself when possible), avoid touching your face and clean your 
hands frequently (with alcohol hand‐rub or soap and water). 
 
There is also a significant risk of direct transfer of the virus on to mucous membranes by droplet 
transmission, that is, by direct impact of larger infectious virus droplets generated from the patient’s 
respiratory tract landing directly in your eyes, nose or mouth. This is most likely to happen if you are 
within 1 meter of the patient. This risk is managed by use of appropriate PPE (surgical facemask and 
eye protection) and by encouraging the patient to wear a surgical facemask or cover their nose and 
mouth when coughing or sneezing (respiratory hygiene and cough etiquette). 
 
There is evidence that airborne transmission can occur when certain procedures (Aerosol Generating 
Procedures (AGPs)) are performed. The biggest risk is related to a healthcare worker performing 
endotracheal intubation. 
 
Keeping safe means focusing on the major identifiable risk. In almost all healthcare settings the 
greatest risks of infection of healthcare workers are likely to be related to anxiety, fatigue, 
distraction and multi‐tasking in critical situations resulting in unintended contact of contaminated 
hands with the eyes, nose or mouth. 
Infection Prevention & Control (IP&C), Personal Protective Equipment (PPE) 
The HPSC has provided detailed guidance on IP&C and PPE requirements for healthcare workers 
at www.HPSC.ie. This guidance from the HPSC should be followed and appropriate PPE used for all 
potential COVID‐19 patients. If AGPs are being performed a surgical facemask is not sufficient 
therefore a properly fitted respirator mask (FFP2) is required. All patients with respiratory symptoms 
should have a surgical facemask applied. 
 
Case Definition – The current HPSC screening case definition for COVID‐19 should be used at all 
times. As of today, this includes: all patients with fever/chills, signs & symptoms of respiratory tract 
infection (including cough) or exposure to a confirmed case of COVID‐19. 
 
Please check HPSC for daily changes to case definition, as it is regularly updating. 
  
 
As COVID‐19 becomes more prevalent in the community, the clinical index of suspicion for COVID‐19 
infection should increase also. 
 
Training & Education 
Training at all levels remains important. The COVID‐19 pandemic is likely to persist for some time, so 
we must give thought to how training continues in this new environment. Training and education 
(including assessment & examinations) should be conducted in such a way that infection risk is 
minimised. This may require delivery on‐line or in smaller groups than normal to facilitate social 
distancing. HPSC advice for contacts and symptomatic cases should also be followed here. 
 
PHECC recommends that mouth to mouth or mouth to mask ventilation should not be taught in the 
current situation. Such elements of training may be omitted and taught at a later date. 
Public Awareness 
All PHECC responders and practitioners are in a position to take a lead in ensuring that important 
public health messages regarding hand washing, cough etiquette and social distancing are 
reinforced. This can be particularly effective when good behaviour is modelled to others. 
Personal Well Being 
This will be a difficult time for everyone in the health services including PHECC responders and 
practitioners. Many of you will work long hours and may become ill yourselves. As with all calls, 
personal safety comes first. A sick responder or practitioner cannot help others. So please ensure 
you use your PPE and take time to look after your own physical and mental well‐being. PHECC will 




Responders may encounter patients with suspected COVID‐19 within their workplace or when 
tasked to normal everyday emergency incidents (Firefighters etc.). Responders may also come across 
an incident by chance where pre‐hospital emergency care is required. 
 
Standard infection control precautions should be applied when treating all patients. 
Patients should be treated according to CPGs, however if there is a presentation as outlined in the 
‘case definition’ above then the patient should be treated as a suspected COVID‐19 case. Such 
patients should have a surgical facemask applied during contact time to limit the spread through 
droplet dispersion. 
 
Patients in cardiac arrest should have compression only CPR applied. Responders who are trained to 
use a BVM may do so but should ensure a viral filter (compliant with BS EN ISO23328‐1:2008) is 
attached. To ensure a good seal on the facemask, to minimise droplet risk, the two‐person operation 
of the BVM is recommended. 
 
Oxygen – if responders are administering oxygen it should be administered at the lowest 
appropriate flow rate, with a surgical facemask over same if patient tolerates this. 
 
Suctioning – should be avoided where possible. Portable suction units entrain and exhale room air, 
which although not directly from the patient, may contribute to droplet dispersion. This is 
particularly important in confined spaces (e.g. first aid room etc.). 
Practitioners 
Oxygen – if required, should be administered at the lowest appropriate flow rate, with a surgical 
facemask over same if patient tolerates this. 
 
Aerosol Generating Procedures (AGPs) – AGPs include tracheal intubation, extubation, positive 
pressure ventilation (PPV) via BVM and suctioning. AGPs should be avoided where possible, as 
outlined above. Where an AGP is necessary, this should take place in a well‐ventilated area, with 
appropriate PPE as outlined above. If an AGP is necessary in the ambulance, the vehicle should be 
stopped temporally to allow the procedure to be carried out safely and efficiently (doors may be 
opened unless inclement weather increases the risk of turbulent airflow in the patient 
compartment). Patients requiring PPV during transfer should, where possible, have a closed circuit; 
i.e. SGA/filter/catheter mount/BVM. This is to minimise the risk of exposure and minimise the 
number of practitioners required to manage the airway and ventilator support. 
Of note, nebulisation is not considered by the HPSC as an AGP. 
 
Oropharyngeal Suctioning – should be avoided where possible. Portable suction units entrain and 
exhale room air, which although not directly from the patient, may contribute to droplet dispersion. 
This is particularly important in confined spaces (e.g. ambulance with doors closed). 
 
Intubation – should be avoided. Supraglottic airway device is recommended for advanced airway 
management. 
 
Tracheal Suctioning – should be avoided (unless a closed suction system in which staff have been 
trained is used (this is not normal EMS equipment). 
 
Tracheostomy Suctioning – should be undertaken only when absolutely necessary, with great care 
and using a closed suction system wherever possible (again recognising that this is not normal EMS 
equipment). 
 
CPAP – CPAP is an aerosolising procedure and should be avoided in a confined space (e.g. 
ambulance compartment). 
 
CPR – As an AGP, FFP2 mask and other appropriate PPE is required. Compression only CPR should be 
commenced until an appropriately fitting BVM facemask is available for ventilations. A well‐fitting 
supraglottic airway should be placed as soon as practical. PPV via SGA or BVM facemask should 
ensure a good seal to minimise droplet risk. The two person BVM facemask process should be 
utilised when manpower permits. A viral filter (compliant with BS EN ISO23328‐1:2008) should be 
used with BVM via facemask and SGA at all times. 
 
Nebulisation – As with oxygen delivery, nebulisers should be delivered with a surgical facemask over 
the nebuliser mask if the patient tolerates it. 
 
Treat & Refer – the delivery of community testing for COVID‐19 represents a significant component 
of the health service response to this situation. PHECC recognises the importance of the NAS 
developing pathways for this under their medical directorate. PHECC is supportive of this 
development in keeping with the philosophy of further developing Treat & Refer CPGs. 
 
Emergency Department Reception – most EDs are implementing COVID‐19 pathways for this patient 
cohort. Practitioners should clarify this with the receiving ED in advance of bringing a patient into 
the ED. Pre arrival notification of COVID‐19 patients requiring resuscitation or early assessment is 
recommended. 
 
Critical Care Transfers – The inter‐hospital transfer of a critically ill COVID‐19 patient represents a 
particular challenge. Wherever possible the NAS specialist retrieval services should be utilised for 
this purpose. The NAS Critical Care and Retrieval Services are contactable via NEOC. 
Dispatch 
PHECC supports the decision of NAS to restrict CFR groups dispatch to choking and cardiac arrest 
calls (with compression only CPR) only for as long as COVID‐19 remains a concern. 
Ambulance Vehicle 
The patient compartment should be cleared of any unnecessary exposed equipment prior to 
transporting a patient with COVID‐19. 
 
Ambulance windows should be kept closed in transit to avoid turbulent airflow and potential 
distribution of droplets. The partition between the patient compartment and the driver 
compartment should be closed if present. If there is no partition, the driver must wear appropriate 
PPE, including surgical facemask, for the full journey. 
 
Decontamination of the ambulance and equipment should be performed according to HPSC 
guidelines. After removal of a COVID‐19 patient from the ambulance, it should be left with doors 
open for at least 20 minutes before cleaning. 
 
It is likely that there will be further updates to this advisory as the COVID‐19 situation develops. 
PHECC is committed to working with all stakeholders to maximise the health service response to this 
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